About this opportunity
Make your mark for patients
We are looking for a Global Payer Asset Head to join our Global Payer Portfolio team, based in Brussels, Belgium; Slough, UK; Atlanta, Georgia; Boston, Massachusetts or Raleigh, North Carolina.
About the role
As Global Payer Asset Head, you will play a pivotal leadership role in shaping global access, pricing, reimbursement, and evidence strategies for an innovative cell therapy portfolio. You will serve as a trusted strategic partner to cross-functional asset teams and executive leaders, ensuring payer perspectives are embedded throughout development and commercialization planning. This role is accountable for driving robust global payer strategies that optimize value for patients, healthcare systems, and UCB while supporting successful launches and long-term asset growth.
Who you'll work with
You will work closely with the Vice President, Health Technology Assessment & Payers, global asset leaders, access and pricing experts, health economics professionals, evidence generation teams, and regional and local market access organizations. You will lead a matrixed payer sub-team and collaborate with internal and external stakeholders to ensure access considerations are integrated into key strategic decisions throughout the asset lifecycle.
What you'll do
Co-create long-term global asset strategy and lifecycle planning.
Lead global access, pricing, and payer evidence strategies.
Direct a high-performing cross-functional payer sub-team.
Shape value propositions through payer insights and market research.
Integrate payer requirements into evidence generation plans.
Support global launch readiness and access strategy execution.
Interested? For this role we're looking for the following
Minimum Requirements
Advanced degree in life sciences, pharmacy, medicine, economics, or related field.
8+ years in market access, pricing, health economics, or payer strategy.
Experience developing global access and reimbursement strategies.
Knowledge of U.S. and major international healthcare systems.
Proven leadership in complex matrixed organizations.
Strong communication, analytical, and strategic planning skills.
Preferred Requirements
PhD, PharmD, MD, MBA, or equivalent advanced qualification.
Experience supporting innovative therapies or specialty medicines.
Expertise in health technology assessment and reimbursement submissions.
Experience with payer evidence generation and health economic modeling.
Established network within payer, policy, or market access communities.
Demonstrated success influencing senior stakeholders globally.
Are you ready to ‘go beyond’ to create value and make your mark for patients? If this sounds like you, then we would love to hear from you!
About us
UCB is a global biopharmaceutical company, focusing on neurology and immunology. We are over 9.000 people in all four corners of the globe, inspired by patients and driven by science.
Why work with us?
At UCB, we don’t just complete tasks, we create value. We aren’t afraid to push forward, collaborate, and innovate to make our mark for patients. We have a caring, supportive culture where everyone feels included, respected, and has equal opportunities to do their best work. We ‘go beyond’ to create value for our patients, and always with a human focus, whether that’s on our patients, our employees, or our planet. Working for us, you will discover a place where you can grow, and have the freedom to carve your own career path to achieve your full potential.
At UCB, we’ve embraced a hybrid-first approach to work, bringing teams together in local hubs to foster collaborative curiosity. Unless expressly stated in the description or precluded by the nature of the position, roles are hybrid with 40% of your time spent in the office.
UCB is an equal opportunity employer. All employment decisions will be made without regard to any characteristic protected by applicable laws.
Should you require any adjustments to our process to assist you in demonstrating your strengths and capabilities contact us on EMEA-Reasonable_Accommodation@ucb.com. Please note should your enquiry not relate to adjustments; we will not be able to support you through this channel.
Job details
How this role compares
Computed from every other active Market Access role in our database, not just this employer's listings.
We currently track 554 comparable Market Access roles across 84 biopharma companies.
Salary context
150 of 554 peers report a salary range (USD, annualized)
Peers share this role's job function. This posting doesn't list a seniority level, so peers aren't narrowed by seniority either -- the range below may span more levels than usual.
Where these roles are based
Top locations among the 554 comparable roles
+ 47 more countries
Seniority mix
400 of 554 peers have a known seniority level
Therapeutic area mix
105 of 554 peers have a known therapeutic area; the rest are genuinely unlabeled, not hidden
Similar opportunities
The closest matches from our peer group, ranked by how similar they are, not how well you'd qualify for them -- treat this as market context, not a guaranteed shortlist; a weak match is labeled as one below.
Notify me about similar jobs
Get an email when we spot other openings like this one – same job function, comparable seniority, roles you'd actually want to see.
Or follow a whole field: get every new Market Access job in the United Kingdom, and choose locations and companies.
How we calculate "similar"
No black box, no LLM guesswork: a deterministic score built from four normalized attributes. Here's this role's own peer group at different match levels, so you can see the mechanism, not just the result.
Every comparison starts from the same 100-point budget: 25 for working in the same function, 40 for the same therapeutic area, 20 for the same or adjacent seniority, 15 for the same country. A dimension we can't confirm on both sides contributes nothing, never a guess, never a free pass.
0 points, never a partial guess. A role we know almost nothing about beyond its function bottoms out at 25%; it never inflates to 100% just because there's little to compare against. Seniority uses a defined ladder (Associate → Manager → Associate Director → Senior → Principal → Director → Senior Director → Executive/VP) so "Director" and "Senior Director" count as adjacent, but "Director" and "Executive/VP" do not.